AXL as a therapeutic target in STK11 mutant NSCLC

被引：0
|
作者：
Blo, Magnus
Rayford, Austin
Madeleine, Noelly
Gartner, Fabian
Bohan, Dana
Ruggio, Natalie
Li, Huiyu
Girard, Luc
Brekken, Rolf
Minna, John
Anerud, Marianne
Maury, Wendy
Gorcea-Carson, Claudia
Gausdal, Gro
Micklem, David R.
McCracken, Nigel
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3245
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Probing Mutant KRAS, STK11, KEAP1 in NSCLC
    Poh, Alissa
    CANCER DISCOVERY, 2022, 12 (10) : 2226 - 2226
  • [2] Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC
    Ricciuti, Biagio
    Garassino, Marina Chiara
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (06) : 877 - 882
  • [3] EGFR inhibition decreases immunosuppressive cytokines and reduces growth in STK11 mutant NSCLC
    Lazdun, Yelena
    Greenlees, Lydia
    Wu, Song
    Holoweckyj, Nicholas
    Pilataxi, Fernanda
    Hayes, Susana
    Higgs, Brandon
    Streicher, Katie
    CANCER RESEARCH, 2022, 82 (12)
  • [4] Immunogenomic analysis identifies the complement pathway as a therapeutic target in STK11 mutant non-small cell lung cancer
    Yau, Edwin H.
    Kandar, Bojidar
    Deng, Lei
    Chen, Te-An
    Bshara, Wiam
    Glenn, Sean
    Pabla, Sarabjot
    Papanicolau-Sengos, Antonios
    Nesline, Mary
    Chen, Hongbin
    Early, Amy
    Morrison, Carl
    Dy, Grace
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Different STK11 Mutation Status Defines Various TIME in NSCLC
    Chen, X.
    Zheng, J.
    Lu, J.
    Liu, W.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S151 - S151
  • [6] Decoding Critical Targets of LKB1/STK11 in NSCLC
    Shaw, R. J.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S5 - S5
  • [7] STK11 Loss Stabilizes MCL1 and Confers Targetable Drug Resistance in KRAS Mutant NSCLC
    Kahle, Michael
    Akbay, Esra
    Christensen, Camilla
    Sholl, Lynette
    Becker, Jeffrey
    Soucheray, Margaret
    Chen, Zhao
    Pulido, Ines
    Kikuchi, Eiki
    Gao, Yandi
    Dennis, Peter
    Qiu, Wei
    Al-Shahrour, Fatima
    Johnson, Neil
    Awad, Mark
    Carretero, Julian
    Wong, Kwok-Kin
    Shimamura, Takeshi
    FASEB JOURNAL, 2017, 31
  • [8] Association of NEDD9 Expression and Survival of Patients with KRAS Mutant and STK11 Mutant Non-Small Cell Lung Cancer (KRASMUT/STK11MUT-NSCLC)
    Judd, J.
    Gandhi, N.
    Xiu, J.
    Deneka, A.
    Khan, H.
    Karim, N. A.
    Liu, S. V.
    Naqash, A. R.
    Borghaei, H.
    Golemis, E.
    Hemenway, G.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S168 - S169
  • [9] Emerging Therapeutic Implications of STK11 Mutation: Case Series
    Laderian, Bahar
    Mundi, Prabhjot
    Fojo, Tito
    E. Bates, Susan
    ONCOLOGIST, 2020, 25 (09): : 733 - 737
  • [10] Tumor-Derived Complement C3 as a Therapeutic Target in STK11 Mutant Non-Small Cell Lung Cancer
    Yau, E.
    Suzuki, S.
    Kandar, B.
    Ting, C.
    Giridharan, T.
    Stokolosa, A.
    Khan, A. N.
    Segal, B.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S86 - S86
12345